Company Overview - TME's online music paying users reached 125.7 million in 3Q25, with a paying ratio of 22.8%[8] - The platform boasts over 260 million music and audio tracks[12] - TME's last twelve months (LTM) total revenues as of 3Q25 were RMB 31.7 billion, with an adjusted net margin of 30.7%[12] - The company holds a strong cash position with RMB 36.08 billion in cash, cash equivalents, term deposits, and short-term investments[13] - Online music MAUs reached 551 million, with a monthly ARPPU of RMB 11.9, representing a YoY growth of 10.2%[13] Financial Highlights - Revenue from online music services in 3Q25 reached RMB 6.97 billion, a 27.2% YoY increase[36] - Revenue from music subscriptions in 3Q25 was RMB 4.50 billion, a 17.2% YoY increase[36] - Other online music services generated RMB 2.47 billion in revenue, a 50.6% YoY increase[36] - The online music monthly ARPPU in 3Q25 was RMB 11.9, a 10.2% YoY increase[37] - Non-IFRS net profit for 3Q25 was RMB 2.48 billion, a 27.7% YoY increase[37]

Financial Performance - Total sales reached $1.9 billion, a 6% year-over-year increase, with specialties-driven sales up by 3%[5] - Adjusted EBITDA increased by 4% year-over-year to $398 million[5] - Specialties-driven sales amounted to $1.5 billion, with an EBITDA of $251 million[5] Segment Performance - **Industrial Products:** Sales were $295 million, and EBITDA was $67 million, with a 23% EBITDA margin[8] - **Potash:** Sales increased to $453 million, and EBITDA reached $169 million, with a 37% EBITDA margin; average potash CIF price was $353 per ton[13, 16] - **Phosphate Solutions:** Sales were $605 million, and EBITDA was $134 million, with a 22% EBITDA margin; Phosphate Specialties sales were $348 million with $51 million EBITDA, while Phosphate Commodities sales were $257 million with $83 million EBITDA[19, 21] - **Growing Solutions:** Sales were $561 million, and EBITDA was $50 million, with a 9% EBITDA margin[23] Financial Position - Available cash resources totaled $1.5 billion[40] - Net debt to adjusted EBITDA ratio was 1.4x[40] - Quarterly dividend was $62 million, resulting in an annual yield of 2.8%[40] Guidance - The company maintains its full-year 2025 guidance for specialties-driven EBITDA between $0.95 billion and $1.15 billion[45] - Potash sales volumes are expected to be between 4.3 million metric tons and 4.5 million metric tons[45]

Financial Performance & Forecast - ORIX revised its FY26.3 net income forecast upward to 440 Billion JPY, a 15.8% increase from the previous forecast of 380 Billion JPY[6, 14] - The company increased its share buyback program to 150 Billion JPY, a 50% increase from the initial 100 Billion JPY program[6, 10] - H1 net income reached 271.1 Billion JPY, achieving 71% of the original full-year target and 62% of the revised forecast[13] - The company expects a full-year ROE in the 10% range, with H1 ROE hitting 12.7%, up 3.9 percentage points from the end of FY25.3[13, 21] Capital Recycling & Investment - Capital gains for H1 FY26.3 reached 157.1 Billion JPY, with expectations of further gains in H2[27] - The company launched its first domestic PE fund with a total size of 2.5 Billion USD[6] - ORIX sold stakes in Greenko, Ormat, ORIX Asset Management and Loan Services Corp, and Nissay Leasing[6] Segment Performance - Segment profits increased by 42% YoY to 409.4 Billion JPY[35] - Environment and Energy segment profits increased sharply by 117.3 Billion JPY due to the Greenko exit, which included a 95 Billion JPY gain on sale/valuation gains[34] - Insurance segment saw higher investment income, contributing to overall profit growth[35] Shareholder Returns - The company increased the full-year dividend forecast to 153.67 JPY per share, a 16.3% increase[6, 14] - The company anticipates a full-year total payout ratio of 73%[15]

GenScript Biotech Corporation Overview - GenScript Biotech Corporation aims to be a leading global CDMO, known for cutting-edge technology, and a creator of solutions for a better life through bio-innovation[6] - The company's growth framework is built on innovation in DNA synthesis & design, protein design & engineering, and cell design & engineering[7] - The group's cash position is $966.6 million[11] - GenScript has a global presence, serving over 100 countries and regions with 200,000+ customers[14] Business Strategy and Financial Goals - By 2035, GenScript aims for $3 billion in revenue with over 20% operating margin, $3 billion accumulated licensing revenue, 50% revenue from products, and over 80% revenue from high-margin markets[20, 46] - The company is focusing on high-quality growth with better profitability[20] - GenScript is leveraging core technology advantages to accelerate products and high-value licensing, building a new growth engine with AI and digital engine[20] GenScript Life Science Group (LSG) - GenScript LSG has over 239,500 customers and 3,300+ employees, with 10% in R&D[59] - Accumulated citations of GenScript services & products in customer research publications exceed 112,200[65] - TurboCHOTM can produce antibodies from sequence in 5 days[98] ProBio (Biologics CRDMO) - ProBio aims to be a leading global CDMO, enabling customers to deliver life-changing therapies[6, 127] - The company has $371.1 million in cash position[137] - The biologics CDMO market is projected to be a $16 billion market with a 12% CAGR, while the CGT CDMO market is at $5.6 billion[166] - In vivo CAR-T trial starts grew 220% from 2024 to 2025[166] Bestzyme (Industrial Synthetic Biology) - Bestzyme's vision is to be the creator of solutions for a better life, powered by leading bio-innovation[6, 224] - The company has over 40% of staff in R&D, 60+ granted patents, and 130+ patent applications[233] - Bestzyme has a 23% revenue CAGR and 22% gross profit CAGR in 2022-2024[233]

Financial Performance - Fortive's revenue reached $4.1 billion, with a ~30% Adjusted EBITDA Margin[8] - The company generated $1.2 billion in Adjusted EBITDA[8] - Free cash flow amounted to $0.9 billion, exceeding 100% conversion on Adjusted Net Income[8] - Adjusted Gross Profit Margin stood at ~65%[8] - Core revenue growth from FY 2019 to FY 2024 was 4%, but only 2% in TTM Q3 2025[8, 9] Segment Performance - Intelligent Operating Solutions (IOS) reported $2.8 billion in revenue with a 35% Adjusted EBITDA Margin[8] - Advanced Healthcare Solutions (AHS) achieved $1.3 billion in revenue with a 27% Adjusted EBITDA Margin[8] Capital Allocation - Fortive deployed $1 billion in Q3 for share repurchases, representing approximately 21 million shares or 6% of fully diluted shares outstanding[12] Strategic Initiatives - The company completed the separation of its former Precision Technologies segment on June 28, 2025[4] - Fortive is focused on faster profitable organic growth powered by the Fortive Business System (FBS)[11]

Baird Global Industrial Conference Lucian Boldea, President and CEO Mike Discenza, Vice President and CFO The Company cautions that actual results may differ materially from those projected or implied in forward-looking statements due to a variety of important factors, including: fluctuations in customer demand for the Company's products or services; unanticipated changes in business relationships with customers or their purchases from the Company; changes in the financial health of the Company's customers, ...

Business Updates - Oklo was selected for three DOE Reactor Pilot Program projects, potentially accelerating deployment timelines[17, 20, 21] - Groundbreaking for the Aurora-INL powerhouse was completed in September, with site earthworks beginning in October[18, 26, 27] - Atomic Alchemy targets first operations by July 2026, focusing on isotope production[18, 31] - The company announced a Fuel Recycling Facility as phase I of an advanced fuel center in Tennessee, with a potential investment of up to $168 billion[19, 41, 44] - Oklo signed a Joint Technology Development Agreement with Blykalla and a fuel fabrication and manufacturing partnership with newcleo to collaborate on advanced nuclear ecosystem[17, 48, 50] Financial Highlights - The company's 3Q 2025 loss from operations was $363 million, driven by payroll, general business expenses, and non-cash stock-based compensation[52, 54] - The 3Q 2025 loss before income taxes was $292 million, derived from the loss from operations adjusted for net interest and dividend income of approximately $71 million[52] - Year-to-date 2025 cash used in operating activities totaled $487 million, including a net loss of $642 million, adjusted primarily for non-cash charges[53] - As of September 30, 2025, Oklo had cash and marketable securities totaling $1184 billion, including $4100 million in cash and equivalents and $7735 million in marketable securities[19, 54, 55]

Fiscal Year 2025 Performance - Amdocs achieved revenue growth of 3.1% year-over-year[14] - The company's non-GAAP operating margin increased by 300 basis points year-over-year to 21.4%[14] - Non-GAAP EPS grew by 8.5% year-over-year[14] - Cloud revenue now accounts for over 30% of total revenue, demonstrating double-digit growth[15, 55] - Managed services reached a record 66% of total revenue[16] Q4 FY2025 Results - Revenue reached $1.15 billion, up approximately 2.8% year-over-year[18] - Non-GAAP operating margin was 21.6%, a 290 basis point increase year-over-year[18] - Non-GAAP EPS was $1.83, above the guidance midpoint[18] - The 12-month backlog increased to $4.19 billion, a 3.2% year-over-year increase[18] FY2026 Outlook - The company projects revenue growth of 1.0% to 5.0% year-over-year in constant currency, with a midpoint of 3.0%[41] - Non-GAAP EBIT margin is expected to be 21.3% to 21.9%, with a midpoint of 21.6%, up 20 basis points year-over-year[41] - Non-GAAP EPS growth is projected to be 4.0% to 8.0%, with a midpoint of 6%[41] - Free cash flow is estimated between $710 million and $730 million[41]

Company Overview and Strategy - MicroVision is a leading provider of lidar hardware and software solutions for Automotive, Industrial, Smart Infrastructure, and Robotics markets[7] - The company focuses on high-margin software revenue and revenue-ready lidar products for Automotive and Industrial markets[7] - MicroVision has a strong CAGR potential driven by design RFQs and holds over 700 patents[7] - The company is focused on optimizing near-term applications in the ADAS value chain, particularly L2 and L3 automation[31] Product Portfolio - MicroVision offers MOVIA L, a lidar sensor for Industrial, Smart cities, and short-range automotive applications[8, 21] - MOVIA S is the next evolution of MOVIA L, with a smaller form factor for specific automotive applications[23] - MAVIN N is a MEMS-based lidar sensor with perception software for Auto OEMs and Tier 1s[9, 26] - PERCEPTION software processes data from lidar sensors to enable OEMs to achieve the best driving application[8, 29] Financial Performance - Q3 2024 revenue was $190 thousand[33] compared to $1047 thousand in Q3 2023[33], a decrease primarily due to a delayed order from a non-automotive customer[34] - Adjusted Gross Profit for Q3 2024 was $(32) thousand, resulting in a margin of (17%)[33] - Net cash used in operations in Q3 2024 was $141 million[35] - Total liquidity is $234 million, including $81 million in cash and cash equivalents, $123 million availability under the existing ATM facility, and $30 million availability under the Convertible Note[38]

Company Overview - Quest Resource Holding Corporation (QRHC) is a national provider of waste & recycling solutions to large businesses [1,8] - The company serves a $200B+ North American waste and recycling industry [10] - Quest offers expertise with 130+ waste streams and has a nationwide footprint, delivering services in every zip code in the U S [10] - The company focuses on large clients with complex waste streams, including Fortune 1000 businesses [11,13] Financial Performance - The company has experienced ~20% CAGR in Gross Profit dollars from 2016 to 2024 [14] - Quest's revenue for the trailing twelve months (TTM) ending in Q3 2025 was $261.281 million [10,17] - Gross profit for the same period was $44.162 million [17] - Adjusted EBITDA for TTM 3Q25 was $8.853 million, representing a 3.4% margin [17,78] Business Strategy - Quest employs an asset-light model, differentiating itself from asset-based integrated majors and fragmented players [34,32,36] - The company's platform delivers nationwide waste and recycling services, regulatory compliance, and comprehensive data reporting [24] - Quest aims to improve clients' sustainability, reduce waste footprint, and improve efficiencies & cost control [24]